| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2018 | Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small cell lung cancer | Yang, SC; Lin, CC; Lai, WW; Chang, SM; Hwang, JS ; Su, WC; Wang, JD | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | | | |
| 2022 | EE161 Loss of Employment Duration and Productivity for Patients With Different Subtypes and Stages of Lung Cancer | Yang, SC; Lai, WW; Wu, TI; Hwang, JS ; Wang, JD; Wang, F | Value in Health 25(12), S84 | | | |
| 2016 | MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma | Lin, CH; Tsai, CH; Yeh, CT; Liang, JL; Hung, WC; Lin, FC; Chang, WL; Li, HY; Yao, YC; Hsu, TI; Lee, YC; Wang, YC; Sheu, BS; Lai, WW; Calkins, MJ; Hsiao, M; Lu, PJ | Oncotarget 7(26):39680-39693 | | | |
| 2018 | Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis | Lin, CY; Hwang, JS ; Wang, WC; Lai, WW; Su, WC; Wu, TY; Yao, G; Wang, JD | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 118(1, Part 2), 215-222 | | | |
| 2021 | QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon | Lai, WW; Chung, CH; Lin, CN; Yang, SC; Hwang, JS ; Wang, JD | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 120(12), 2089-2099 | | | |
